GRIFFIN LABORATORIES (a California Corporation) – Trademark Portfolio

Entity Type: 03

GRIFFIN LABORATORIES (a California Corporation) holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EMOTE. The owner is based in Temecula, CA.

27636 Ynez Road, # L-7199

Temecula, CA 92591

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EMOTE
EMOTE
Registered 2016

Trademark Classifications

GRIFFIN LABORATORIES (a California Corporation)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GRIFFIN LABORATORIES (a California Corporation) have?

GRIFFIN LABORATORIES (a California Corporation) has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GRIFFIN LABORATORIES (a California Corporation) file in?

GRIFFIN LABORATORIES (a California Corporation) files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GRIFFIN LABORATORIES (a California Corporation)'s most well-known trademarks?

GRIFFIN LABORATORIES (a California Corporation)'s registered trademark portfolio includes well-known marks such as EMOTE. These are among 1 currently registered trademark in the portfolio.

What is GRIFFIN LABORATORIES (a California Corporation)'s trademark registration success rate?

GRIFFIN LABORATORIES (a California Corporation) has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.